Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus midazolam for pediatric MRI sedation
ChiCTR1900023334Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children's Medical Centre
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and midazolam (2 arms), sponsored by Guangzhou Women and Children's Medical Centre. Primary endpoint: Sedation success rate. Started May 2019; status: recruiting.
02
Drugs
dexmedetomidinemidazolam
Beyond the preview
Go deeper on ChiCTR1900023334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023334.